CTRI/2023/10/059034尚未招募3 期
Effect of Dapagliflozin and Metformin Combination on Insulin Resistance and Cardiovascular Disease Risk Factors in Drug Naïve Type II Diabetes Mellitus Patients in a Tertiary Care Hospital: An Open Label Randomized Controlled Trial - NI
S Abissha0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Male/female aged 18-60 years
- •2) Newly diagnosed with type 2 diabetes mellitus patients (FBS >126mg/dl and PPBS >200mg/dl)
- •3) HbA1c level 7% to 8%
- •4) Newly diagnosed type II diabetes with or without hypertension and dyslipidemia
排除标准
- •1) Diabetes with renal failure
- •2) Diabetes with liver failure
- •3) Pregnancy and lactation, psychiatric patients
- •4) Age above 60 years
- •5) Patients who are not willing to give informed consent
研究者
相似试验
尚未招募
4 期
Comparative effects of dapagliflozin and metformin in obese diabetic patientsCTRI/2023/11/059814Shobana
进行中（未招募）
1 期
Effects of glucose-lowering interventions in pre-diabetesEUCTR2015-001552-30-DKSteno Diabetes Center A/S160
招募中
不适用
Dapagliflozin add-on to metformin therapy in diabetic patientsCTRI/2022/12/048622Aditya kumar
已完成
1 期
Drug Interaction With MetforminHealthy Male and Female SubjectsNCT00546741AstraZeneca18
招募中
不适用
Effects of dapaglifrogine and metoformine in patients with type 2 diabetes:a randomized controlled studyType 2 diabetesJPRN-UMIN000032296Yokohama City University100